Nitric oxide (NO): an emerging target for the treatment of glaucoma
Cavet, Megan E, Vittitow, Jason L, Impagnatiello, Francesco, Ongini, Ennio, Bastia, Elena
Published in Investigative ophthalmology & visual science (14.08.2014)
Published in Investigative ophthalmology & visual science (14.08.2014)
Get full text
Journal Article
Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the Chorioretina
Muya, Leroy, Kansara, Viral, Cavet, Megan E, Ciulla, Thomas
Published in Journal of ocular pharmacology and therapeutics (01.08.2022)
Published in Journal of ocular pharmacology and therapeutics (01.08.2022)
Get more information
Journal Article
Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
Sheppard, John D., Comstock, Timothy L., Cavet, Megan E.
Published in Advances in therapy (01.04.2016)
Published in Advances in therapy (01.04.2016)
Get full text
Journal Article
Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial
McLaurin, Eugene, Cavet, Megan E, Gomes, Paul J, Ciolino, Joseph B
Published in Optometry and vision science (01.03.2018)
Published in Optometry and vision science (01.03.2018)
Get full text
Journal Article
Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38
Cavet, Megan E, Glogowski, Shellise, Lowe, Ezra R, Phillips, Eric
Published in Journal of ocular pharmacology and therapeutics (01.06.2019)
Published in Journal of ocular pharmacology and therapeutics (01.06.2019)
Get more information
Journal Article
Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies
Fong, Raymond, Cavet, Megan E, DeCory, Heleen H, Vittitow, Jason L
Published in Clinical ophthalmology (Auckland, N.Z.) (01.08.2019)
Published in Clinical ophthalmology (Auckland, N.Z.) (01.08.2019)
Get full text
Journal Article
Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy
Baiula, Monica, Bedini, Andrea, Baldi, Jacopo, Cavet, Megan E, Govoni, Paolo, Spampinato, Santi
Published in Drug design, development and therapy (01.01.2014)
Published in Drug design, development and therapy (01.01.2014)
Get full text
Journal Article
Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells
Spinelli, Sherry L., Xi, Xia, McMillan, David H., Woeller, Collynn F., Richardson, Mary E., Cavet, Megan E., Zhang, Jin-Zhong, Feldon, Steven E., Phipps, Richard P.
Published in Experimental eye research (01.10.2014)
Published in Experimental eye research (01.10.2014)
Get full text
Journal Article
Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells
Cavet, Megan E, Harrington, Karen L, Ward, Keith W, Zhang, Jin-Zhong
Published in Molecular vision (02.09.2010)
Get full text
Published in Molecular vision (02.09.2010)
Journal Article
BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells
Zhang, Jin-Zhong, Cavet, Megan E, VanderMeid, Karl R, Salvador-Silva, Mercedes, López, Francisco J, Ward, Keith W
Published in Molecular vision (08.12.2009)
Get full text
Published in Molecular vision (08.12.2009)
Journal Article
Gas6–Axl Receptor Signaling Is Regulated by Glucose in Vascular Smooth Muscle Cells
Cavet, Megan E, Smolock, Elaine M, Ozturk, Oktay H, World, Cameron, Pang, Jinjiang, Konishi, Atsushi, Berk, Bradford C
Published in Arteriosclerosis, thrombosis, and vascular biology (01.05.2008)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.05.2008)
Get full text
Journal Article